Differences

This shows you the differences between two versions of the page.

--- home:diseases:co-infections [06.07.2011] – paulalbert
+++ home:diseases:co-infections [06.07.2011] – paulalbert
@@ Line 2: / Line 2: @@
 ====== Co-infections ======
+<relatedarticle> [[home:pathogenesis:microbiota|Microbes in the human body]] </article>
 A variety of bacteria, fungi, and viruses are commonly described as co-infections. These include: //Bartonella,// cytomegalovirus, //Borellia, Babesia, Candida, Ehrlicha//, Epstein-Barr virus, and //Rickettsia//. In the absence of a robust immune response, these microbes along with others proliferate inside the human body.
-Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections.
+Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, there is a good chance the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections.
@@ Line 17: / Line 18: @@
-===== Marshall Protocol targets co-infections =====
+===== Marshall Protocol targets "co-infections" =====
 <relatedarticle> [[home:pathogenesis:innate_immunity|Innate immune response and Th1 inflammation]]  </article>
-Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes – including and especially co-infections. One component of the innate immune response is the antimicrobial peptides.
+Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes including "co-infections." One important component of the innate immune response is the antimicrobial peptides.
 {{section>:home:pathogenesis:innate_immunity#antimicrobial_peptides_target_fungi_and_viruses&noheader}}

home/diseases/co-infections.txt · Last modified: 09.14.2022 by 127.0.0.1